Brief: Janux Therapeutics Q1 Basic EPS USD -0.3

Janux Therapeutics

07/05/2024 21:01

May 07 (Reuters) - Janux Therapeutics Q1 net income USD -14.76 million.
* Q1 collaboration revenue USD 1.252 million
* Q1 operating income USD -20.161 million
* Q1 operating expenses USD 21.413 million